Skip to main content
Top
Published in: BMC Clinical Pharmacology 1/2010

Open Access 01-12-2010 | Research article

Knowledge and adherence to antiretroviral therapy among adult people living with HIV/AIDS treated in the health care centers of the association "Espoir Vie Togo" in Togo, West Africa

Authors: Yao Potchoo, Kpatcha Tchamdja, Agnon Balogou, Vincent P Pitche, Innocent P Guissou, Etienne K Kassang

Published in: BMC Clinical Pharmacology | Issue 1/2010

Login to get access

Abstract

Background

The efficiency of antiretroviral therapy (ART) depends on a near perfect level of patients' adherence. The level of adherence of adults HIV-infected patients treated in the HIV/AIDS health care centres of the association "Espoir Vie Togo" in Togo, West Africa is not properly documented. The aim of the present study was to examine by means of self-reports the knowledge, the adherence level and associated factors to antiretroviral therapy (ART) among these patients.

Methods

We conducted a cross-sectional survey among adult people living with HIV/AIDS (PLWHA) through a structured questionnaire.

Results

A total of 99 patients were enrolled. Among them, 55.6% knew the name of antiretroviral agents of regimens prescribed. All patients had a good knowledge of treatment schedule. The treatment regimens based on 2 NRTIs + 1 NNRTI were used in 90% of patients. The average adherence rate was 89.8% of the total doses prescribed while 62.62% of patients showed an adherence rate of 95% or above. The treated groups were similar in term of median % of medication doses taken according to PLWHA epidemiological characteristics. However, patients reported forgetting (34.9%), travel (25.6%), cost of treatment (13.9%) and side effects (11.6%) as the main factors of missing at least once a dose intake.

Conclusion

These results should encourage the association and all the involved actors in the HIV/AIDS's program to strengthen counseling, education and information interventions for HIV-infected patients in order to overcome the potential barriers of poor adherence.
Appendix
Available only for authorised users
Literature
1.
go back to reference Katlama C, Pialoux G, Girard PM: Traitements antirétroviraux. VIH. Edited by: Girard PM, Katlama C, Pialoux G. 2004, Paris: Doin, 299-329. Katlama C, Pialoux G, Girard PM: Traitements antirétroviraux. VIH. Edited by: Girard PM, Katlama C, Pialoux G. 2004, Paris: Doin, 299-329.
2.
go back to reference Fonquerine L, Girard PM: Classification, définitions et facteurs prévisionnels d'évolution de l'infection VIH-1 chez l'adulte. VIH. Edited by: Girard PM, Katlama C, Pialoux G. 2004, Paris: Doin, 53-63. Fonquerine L, Girard PM: Classification, définitions et facteurs prévisionnels d'évolution de l'infection VIH-1 chez l'adulte. VIH. Edited by: Girard PM, Katlama C, Pialoux G. 2004, Paris: Doin, 53-63.
3.
go back to reference McDonnell Holstatd MK, Pace JC, De AK, Ura DR: Factors associated with adherence to antiretroviral therapy. Journal of the Association of Nurses in AIDS Care. 2006, 17 (2): 4-15. 10.1016/j.jana.2006.01.002.CrossRef McDonnell Holstatd MK, Pace JC, De AK, Ura DR: Factors associated with adherence to antiretroviral therapy. Journal of the Association of Nurses in AIDS Care. 2006, 17 (2): 4-15. 10.1016/j.jana.2006.01.002.CrossRef
4.
go back to reference Spire B: Problèmes cliniques et comportementaux liés à la chronicisation de la maladie. Le SIDA 20 ans après: d'une maladie mortelle à une maladie chronique. Actualité et Dossier de Santé Publique. 2002, 09: 23-25. Spire B: Problèmes cliniques et comportementaux liés à la chronicisation de la maladie. Le SIDA 20 ans après: d'une maladie mortelle à une maladie chronique. Actualité et Dossier de Santé Publique. 2002, 09: 23-25.
5.
go back to reference Chesney MA, Morin M, Sherr L: Adherence to HIV combination therapy. Social Science & Medicine. 2000, 50: 1599-1605.CrossRef Chesney MA, Morin M, Sherr L: Adherence to HIV combination therapy. Social Science & Medicine. 2000, 50: 1599-1605.CrossRef
6.
go back to reference Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, Wagener MM, Smith N: Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine. 2000, 133 (Suppl 1): 21-30.CrossRefPubMed Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, Wagener MM, Smith N: Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine. 2000, 133 (Suppl 1): 21-30.CrossRefPubMed
7.
go back to reference Paterson DL, Potoski B, Capitano B: Measurement of adherence to antiretroviral medications. Journal of Acquired Immune Deficiency Syndrome. 2002, 31 (Suppl 2): S103-S106.CrossRef Paterson DL, Potoski B, Capitano B: Measurement of adherence to antiretroviral medications. Journal of Acquired Immune Deficiency Syndrome. 2002, 31 (Suppl 2): S103-S106.CrossRef
8.
go back to reference Fisher JD, Fisher WA, Amico KR, Harman JJ: An information-motivation behavioral skills model of adherence to antiretroviral therapy. Health Psychology. 2006, 25 (4): 462-473. 10.1037/0278-6133.25.4.462.CrossRefPubMed Fisher JD, Fisher WA, Amico KR, Harman JJ: An information-motivation behavioral skills model of adherence to antiretroviral therapy. Health Psychology. 2006, 25 (4): 462-473. 10.1037/0278-6133.25.4.462.CrossRefPubMed
9.
go back to reference Jones DL, McPherson-Baker S, Lydston D, Camille J, Brondolo E, Tobin JN, Weiss SM: Efficacy of a Group Medication Adherence Intervention Among HIV Positive Women: The SMART/EST Women's Project. AIDS Behav. 2007, 11: 79-86. 10.1007/s10461-006-9165-8.CrossRefPubMedPubMedCentral Jones DL, McPherson-Baker S, Lydston D, Camille J, Brondolo E, Tobin JN, Weiss SM: Efficacy of a Group Medication Adherence Intervention Among HIV Positive Women: The SMART/EST Women's Project. AIDS Behav. 2007, 11: 79-86. 10.1007/s10461-006-9165-8.CrossRefPubMedPubMedCentral
10.
go back to reference Stone VE, Hogan JW, Schuman P, Rompalo AM, Howard AA, Korkontzelou C, Smith DK: Antiretroviral regimen complexity, self-reported adherence, and HIV patient's understanding of their regimens: Survey of women in the HER study. Journal of Acquired Immune Deficiency Syndrome. 2001, 28 (Suppl 2): 124-131.CrossRef Stone VE, Hogan JW, Schuman P, Rompalo AM, Howard AA, Korkontzelou C, Smith DK: Antiretroviral regimen complexity, self-reported adherence, and HIV patient's understanding of their regimens: Survey of women in the HER study. Journal of Acquired Immune Deficiency Syndrome. 2001, 28 (Suppl 2): 124-131.CrossRef
11.
go back to reference Remien RH, Hirky AE, Johnson MO, Weinhardt LS, Whittier D, Minh Le G: Adherence to medication treatment: A qualitative study of facilitators and barriers among a diverse sample of HIV+ men and women in four U.S. cities. AIDS and Behavior. 2003, 7 (suppl 1): 61-72. 10.1023/A:1022513507669.CrossRefPubMed Remien RH, Hirky AE, Johnson MO, Weinhardt LS, Whittier D, Minh Le G: Adherence to medication treatment: A qualitative study of facilitators and barriers among a diverse sample of HIV+ men and women in four U.S. cities. AIDS and Behavior. 2003, 7 (suppl 1): 61-72. 10.1023/A:1022513507669.CrossRefPubMed
12.
go back to reference Simoni JM, Frick PA, Lockhart D, Liebovitz D: Mediators of social support and antiretroviral adherence among an indigent population in New York city. Aids Patient Care and STDs. 2002, 16 (Suppl 9): 431-439. 10.1089/108729102760330272.CrossRefPubMed Simoni JM, Frick PA, Lockhart D, Liebovitz D: Mediators of social support and antiretroviral adherence among an indigent population in New York city. Aids Patient Care and STDs. 2002, 16 (Suppl 9): 431-439. 10.1089/108729102760330272.CrossRefPubMed
13.
go back to reference Goujard C, Bernard N, Sohier N, Peyramond D, Lancon F, Chwalow J, Arnould B, Delfraissy J-F: Impact of a patient education program on adherence to HIV medication: A randomized clinical trial. Journal of Acquired Immune Deficiency Syndrome. 2003, 34 (Suppl 2): 191-194. 10.1097/00126334-200310010-00009.CrossRef Goujard C, Bernard N, Sohier N, Peyramond D, Lancon F, Chwalow J, Arnould B, Delfraissy J-F: Impact of a patient education program on adherence to HIV medication: A randomized clinical trial. Journal of Acquired Immune Deficiency Syndrome. 2003, 34 (Suppl 2): 191-194. 10.1097/00126334-200310010-00009.CrossRef
14.
go back to reference Watt MH, Maman S, Earp JA, Eng E, Setel PW, Golin CE, Jacobson M: "It's all the time my mind": Facilitators of adherence to antiretroviral therapy in a Tanzanian setting. Social Science & Medicine. 2009, 68 (10): 1793-1800.CrossRef Watt MH, Maman S, Earp JA, Eng E, Setel PW, Golin CE, Jacobson M: "It's all the time my mind": Facilitators of adherence to antiretroviral therapy in a Tanzanian setting. Social Science & Medicine. 2009, 68 (10): 1793-1800.CrossRef
15.
go back to reference Hardon AP, Akurut D, Comoro C, Ekezie C, Irunde HF, Gerrits T, Kglatwane J, Kinsman J, Kwasa R, Maridadi J, Moroka TM, Moyo S, Nakiyemba A, Nsimba S, Ogeyi R, Oyabba T, Temu F, Laing R: Hunger, waiting time and transport costs: Time to confront challenges to ART adherence in Africa. AIDS care-psychological and socio-medical aspects of AIDS/HIV. 2007, 19 (5): 658-665.CrossRef Hardon AP, Akurut D, Comoro C, Ekezie C, Irunde HF, Gerrits T, Kglatwane J, Kinsman J, Kwasa R, Maridadi J, Moroka TM, Moyo S, Nakiyemba A, Nsimba S, Ogeyi R, Oyabba T, Temu F, Laing R: Hunger, waiting time and transport costs: Time to confront challenges to ART adherence in Africa. AIDS care-psychological and socio-medical aspects of AIDS/HIV. 2007, 19 (5): 658-665.CrossRef
16.
go back to reference Bangsberg DR, Perry S, Charlebois ED, Clark RA, Robertson M, Zolopa AR, Moss A: Adherence to HAART predicts progressing to Aids. AIDS. 2001, 15 (9): 1181-1183. 10.1097/00002030-200106150-00015.CrossRefPubMed Bangsberg DR, Perry S, Charlebois ED, Clark RA, Robertson M, Zolopa AR, Moss A: Adherence to HAART predicts progressing to Aids. AIDS. 2001, 15 (9): 1181-1183. 10.1097/00002030-200106150-00015.CrossRefPubMed
17.
go back to reference Programme National de Lutte contre le SIDA (PNLS-Togo): Evaluation de la prise en charge thérapeutique des personnes vivant avec le VIH (PVVIH) par les antirétroviraux (ARV) au Togo. 2005, 1-24. Programme National de Lutte contre le SIDA (PNLS-Togo): Evaluation de la prise en charge thérapeutique des personnes vivant avec le VIH (PVVIH) par les antirétroviraux (ARV) au Togo. 2005, 1-24.
18.
go back to reference Coetzee D, Boulle A, Hildebrand K, Asselman V, Van Cutsem G, Goemaere E: Promoting adherence to antiretroviral therapy: the experience from a primary care setting in Khayelitsha, South Africa. AIDS. 2004, 18 (suppl 3): S27-S31. 10.1097/00002030-200406003-00006.CrossRefPubMed Coetzee D, Boulle A, Hildebrand K, Asselman V, Van Cutsem G, Goemaere E: Promoting adherence to antiretroviral therapy: the experience from a primary care setting in Khayelitsha, South Africa. AIDS. 2004, 18 (suppl 3): S27-S31. 10.1097/00002030-200406003-00006.CrossRefPubMed
19.
go back to reference Oyugi JH, Byakika-Tusiime J, Ragland K, Laeyendecker O, Mugerwa R, Kityo C, Mugyenyi P, Quinn TC, Bangsberg DR: Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda. AIDS. 2007, 21 (8): 965-971. 10.1097/QAD.0b013e32802e6bfa.CrossRefPubMed Oyugi JH, Byakika-Tusiime J, Ragland K, Laeyendecker O, Mugerwa R, Kityo C, Mugyenyi P, Quinn TC, Bangsberg DR: Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda. AIDS. 2007, 21 (8): 965-971. 10.1097/QAD.0b013e32802e6bfa.CrossRefPubMed
20.
go back to reference Etard J-F, Lanièce I, Fall MBK, Cilote V, Blazejewski L, Diop K, Desclaux A, Ecochard R, Ndoye I, Delaporte E, ANRS 1215/1290 Study Group: A 84-month follow up of adherence to HAART in a cohort of adult Senegalese patients. Tropical Medicine and International Health. 2007, 12 (10): 1191-1198. 10.1111/j.1365-3156.2007.01910.x.CrossRefPubMed Etard J-F, Lanièce I, Fall MBK, Cilote V, Blazejewski L, Diop K, Desclaux A, Ecochard R, Ndoye I, Delaporte E, ANRS 1215/1290 Study Group: A 84-month follow up of adherence to HAART in a cohort of adult Senegalese patients. Tropical Medicine and International Health. 2007, 12 (10): 1191-1198. 10.1111/j.1365-3156.2007.01910.x.CrossRefPubMed
21.
go back to reference Laniece I, Desclaux A, Ciss M, Diop K, Ndiaye B: L'observance des traitements antirétroviraux et ses déterminants. Analyse quantitative. L'initiative sénégalaise d'accès aux médicaments antirétroviraux. Edited by: Desclaux A, Laniece I, Ndoye I. 2002, Paris ANRS, 97-108. Laniece I, Desclaux A, Ciss M, Diop K, Ndiaye B: L'observance des traitements antirétroviraux et ses déterminants. Analyse quantitative. L'initiative sénégalaise d'accès aux médicaments antirétroviraux. Edited by: Desclaux A, Laniece I, Ndoye I. 2002, Paris ANRS, 97-108.
22.
go back to reference Benjaber K, Rey JL, Himmich H: Etude sur l'observance du traitement antirétroviral à Casablanca. Médecine et maladies infectieuses. 2005, 35: 390-395. 10.1016/j.medmal.2005.04.009.CrossRefPubMed Benjaber K, Rey JL, Himmich H: Etude sur l'observance du traitement antirétroviral à Casablanca. Médecine et maladies infectieuses. 2005, 35: 390-395. 10.1016/j.medmal.2005.04.009.CrossRefPubMed
23.
go back to reference Roux P, Rey JL, Sehonou J, Certain A: L'observance à un mois des patients sida inclus dans l'initiative béninoise d'accès aux antirétroviraux. Bull Soc Pharm Bordeaux. 2004, 143: 19-30. Roux P, Rey JL, Sehonou J, Certain A: L'observance à un mois des patients sida inclus dans l'initiative béninoise d'accès aux antirétroviraux. Bull Soc Pharm Bordeaux. 2004, 143: 19-30.
24.
go back to reference Zachariah R, Van Engelgem I, Massaquoi M, Kocholla L, Manzi M, Suleh A, Phillips M, Borgdorff M: Payment for antiretroviral drugs is associated with a higher rate of patients lost to follow-up than those offered free-of-charge therapy in Nairobi, Kenya. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2008, 102: 288-293. 10.1016/j.trstmh.2007.12.007.CrossRefPubMed Zachariah R, Van Engelgem I, Massaquoi M, Kocholla L, Manzi M, Suleh A, Phillips M, Borgdorff M: Payment for antiretroviral drugs is associated with a higher rate of patients lost to follow-up than those offered free-of-charge therapy in Nairobi, Kenya. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2008, 102: 288-293. 10.1016/j.trstmh.2007.12.007.CrossRefPubMed
25.
go back to reference Vriesendorp R, Cohen A, Kristanto P, Vriejens B, Rakesh P, Anand B, Iwebor HU, Stiekema J: Adherence to HAART therapy measured by electronic monitoring in newly diagnosed HIV patients in Botswana. Eur J Clin Pharmacol. 2007, 63: 1115-1121. 10.1007/s00228-007-0369-2.CrossRefPubMedPubMedCentral Vriesendorp R, Cohen A, Kristanto P, Vriejens B, Rakesh P, Anand B, Iwebor HU, Stiekema J: Adherence to HAART therapy measured by electronic monitoring in newly diagnosed HIV patients in Botswana. Eur J Clin Pharmacol. 2007, 63: 1115-1121. 10.1007/s00228-007-0369-2.CrossRefPubMedPubMedCentral
26.
go back to reference Diabate S, Alery M, Koffi CK: Determinants of adherence to highly active antiretroviral therapy among HIV-1-infected patients in Côte d'Ivoire. AIDS. 2007, 21 (13): 1799-1803. 10.1097/QAD.0b013e3282a5667b.CrossRefPubMed Diabate S, Alery M, Koffi CK: Determinants of adherence to highly active antiretroviral therapy among HIV-1-infected patients in Côte d'Ivoire. AIDS. 2007, 21 (13): 1799-1803. 10.1097/QAD.0b013e3282a5667b.CrossRefPubMed
27.
go back to reference Sethi AK, Celantano DD, Gange SF, Moore RD, Gallant JE: Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance. Clin Infect Dis. 2003, 37: 1112-1118. 10.1086/378301.CrossRefPubMed Sethi AK, Celantano DD, Gange SF, Moore RD, Gallant JE: Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance. Clin Infect Dis. 2003, 37: 1112-1118. 10.1086/378301.CrossRefPubMed
28.
go back to reference Maggiolo F, Ravasio L, Ripamonti D, Gregis G, Quinzan G, Arici C, Airoldi M, Suter F: Similar adherence rates favor different virologic outcomes for patients treated with nonnucleoside analogues or protease inhibitors. Clin Infect Dis. 2005, 40: 158-163. 10.1086/426595.CrossRefPubMed Maggiolo F, Ravasio L, Ripamonti D, Gregis G, Quinzan G, Arici C, Airoldi M, Suter F: Similar adherence rates favor different virologic outcomes for patients treated with nonnucleoside analogues or protease inhibitors. Clin Infect Dis. 2005, 40: 158-163. 10.1086/426595.CrossRefPubMed
29.
go back to reference Bangsberg DR: Less than 95% adherence to nucleoside reverse-transcriptase inhibitors therapy can lead to viral suppression. Clin Infect Dis. 2006, 43: 939-941. 10.1086/507526.CrossRefPubMed Bangsberg DR: Less than 95% adherence to nucleoside reverse-transcriptase inhibitors therapy can lead to viral suppression. Clin Infect Dis. 2006, 43: 939-941. 10.1086/507526.CrossRefPubMed
30.
go back to reference Fogarty L, Roter D, Larson S, Burke J, Gillespie J, Levy R: Patient adherence to HIV medication regimens: a review of published and abstracts reports. Patient Education and Counselling. 2001, 46 (2): 93-108. 10.1016/S0738-3991(01)00219-1.CrossRef Fogarty L, Roter D, Larson S, Burke J, Gillespie J, Levy R: Patient adherence to HIV medication regimens: a review of published and abstracts reports. Patient Education and Counselling. 2001, 46 (2): 93-108. 10.1016/S0738-3991(01)00219-1.CrossRef
31.
go back to reference Laniece I, Ciss M, Desclaux A, Diop K, Mbodj F, Ndiaye B, Sylla O, Delaporte E, Ndoye I: Adherence to HAART and its principal determinants in a cohort of Senegalese adults. AIDS. 2003, 17 (suppl 3): S103-S108. 10.1097/00002030-200317003-00014.CrossRefPubMed Laniece I, Ciss M, Desclaux A, Diop K, Mbodj F, Ndiaye B, Sylla O, Delaporte E, Ndoye I: Adherence to HAART and its principal determinants in a cohort of Senegalese adults. AIDS. 2003, 17 (suppl 3): S103-S108. 10.1097/00002030-200317003-00014.CrossRefPubMed
32.
go back to reference Weiser S, Wolfe W, Bangsberg D, Thior I, Gilberg P, Makhema J, Kebaabetswe P, Dickenson D, Mompati K, Essex M, Marlink R: Barriers to antiretroviral adherence for patients living with HIV infection and AIDS in Botswana. J Acquir Immune Defic Syndr. 2003, 34 (3): 281-288. 10.1097/00126334-200311010-00004.CrossRefPubMed Weiser S, Wolfe W, Bangsberg D, Thior I, Gilberg P, Makhema J, Kebaabetswe P, Dickenson D, Mompati K, Essex M, Marlink R: Barriers to antiretroviral adherence for patients living with HIV infection and AIDS in Botswana. J Acquir Immune Defic Syndr. 2003, 34 (3): 281-288. 10.1097/00126334-200311010-00004.CrossRefPubMed
33.
go back to reference Au JT, Kayitenkore K, Shutes E, Karita E, Peters PJ, Tichacek A, Allen SA: Access to adequate nutrition is a major potential obstacle to antiretroviral adherence among HIV-infected individuals in Rwanda [Letter]. AIDS. 2006, 20 (16): 2116-2118. 10.1097/01.aids.0000247580.16073.1b.CrossRefPubMed Au JT, Kayitenkore K, Shutes E, Karita E, Peters PJ, Tichacek A, Allen SA: Access to adequate nutrition is a major potential obstacle to antiretroviral adherence among HIV-infected individuals in Rwanda [Letter]. AIDS. 2006, 20 (16): 2116-2118. 10.1097/01.aids.0000247580.16073.1b.CrossRefPubMed
34.
go back to reference Bhengu BR, Ncama BP, McInerney PA, Wantland DJ, Nicholas PK, Corless IB, McGibbon CA, Davis SM, Nicholas TP, Ros AV: Symptoms experienced by HIV-infected individuals on antiretroviral therapy in Kwazulu-Natal, South Africa. Applied Nursing Research. Correct Proof 2009, Bhengu BR, Ncama BP, McInerney PA, Wantland DJ, Nicholas PK, Corless IB, McGibbon CA, Davis SM, Nicholas TP, Ros AV: Symptoms experienced by HIV-infected individuals on antiretroviral therapy in Kwazulu-Natal, South Africa. Applied Nursing Research. Correct Proof 2009,
35.
go back to reference McDonnell Holstatd MK, Pace JC, De AK, Ura DR: Factors associated with adherence to antiretroviral therapy. Journal of the Association of Nurses in AIDS Care. 2006, 17 (2): 4-15. 10.1016/j.jana.2006.01.002.CrossRef McDonnell Holstatd MK, Pace JC, De AK, Ura DR: Factors associated with adherence to antiretroviral therapy. Journal of the Association of Nurses in AIDS Care. 2006, 17 (2): 4-15. 10.1016/j.jana.2006.01.002.CrossRef
36.
go back to reference Salmon-Ceron D, Deleuze J, Coste J, Guerin C, Guinburg C, Blanche P, Finkielsztejn L, Pecqueux L, Chaput S, Gorin I, Sicard D: Enquête sur l'observance des traitements antirétroviraux comportant un inhibiteur de protéase chez des patients infectés par le VIH. Paris, Masson. 2000, 297-302. Salmon-Ceron D, Deleuze J, Coste J, Guerin C, Guinburg C, Blanche P, Finkielsztejn L, Pecqueux L, Chaput S, Gorin I, Sicard D: Enquête sur l'observance des traitements antirétroviraux comportant un inhibiteur de protéase chez des patients infectés par le VIH. Paris, Masson. 2000, 297-302.
Metadata
Title
Knowledge and adherence to antiretroviral therapy among adult people living with HIV/AIDS treated in the health care centers of the association "Espoir Vie Togo" in Togo, West Africa
Authors
Yao Potchoo
Kpatcha Tchamdja
Agnon Balogou
Vincent P Pitche
Innocent P Guissou
Etienne K Kassang
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Clinical Pharmacology / Issue 1/2010
Electronic ISSN: 1472-6904
DOI
https://doi.org/10.1186/1472-6904-10-11

Other articles of this Issue 1/2010

BMC Clinical Pharmacology 1/2010 Go to the issue